Polycationic Photosensitizers as Effective Anticancer Agents That Destroy Cancer Stem Cells, Cancer Vascularization and Induce Protective Desmoplastic Reaction around Lung Cancers

Author:

Kogan Evgeniya1,Meerovich Gennady23,Karshieva Saida45,Makarova Elena6ORCID,Romanishkin Igor2ORCID,Akhlyustina Ekaterina3,Meerovich Irina7,Zharkov Nikolay8ORCID,Kharnas Sergey9,Levkin Vladimir9,Demura Sofya1,Chen Zhilong10,Loschenov Victor23,Reshetov Igor11

Affiliation:

1. Institute of Clinical Morphology and Digital Pathology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119992, Russia

2. Prokhorov General Physics Institute of the Russian Academy of Sciences, Moscow 119991, Russia

3. Institute of Engineering Physics for Biomedicine, National Research Nuclear University MEPhI, Moscow 115409, Russia

4. N.N. Blokhin National Medical Research Center of Oncology, Moscow 115478, Russia

5. Research and Educational Center of Biomedical Engineering, National University of Science and Technology MISIS, Moscow 119049, Russia

6. Organic Intermediates and Dyes Institute, Moscow 123001, Russia

7. A.N. Bach Institute of Biochemistry, Research Center of Biotechnology of the Russian Academy of Sciences, Moscow 119071, Russia

8. Center of Digital Biodesign and Personalized Healthcare, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119992, Russia

9. N.V. Sklifosovskiy Institute of Clinical Medicine, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119992, Russia

10. Huadong Hospital, Fudan University, Shanghai 200433, China

11. L.L. Levshin Institute of Cluster Oncology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119992, Russia

Abstract

PDT using PSs based on polycationic derivatives of synthetic bacteriochlorin against Lewis lung carcinoma provides effective inhibition of tumor growth with an increase in the lifespan and survival of mice in the group. PDT with polycationic photosensitizers destroys CSCs and tumor neovascularization, and activates the desmoplastic reaction. These results open up new opportunities for increasing the effectiveness of treatment and reducing the incidence of relapses and metastases after PDT.

Funder

Russian Science Foundation

National Natural Science Foundation of China

Publisher

MDPI AG

Reference28 articles.

1. Averyanov, A. (2020). Difficult to Diagnose Rare Diffuse Lung Disease, Elsevier.

2. Goldblum, J.R., Lamps, L.W., McKenney, J.K., Myers, J.L., Ackerman, L.V., and Rosai, J. (2018). Rosai and Ackerman’s Surgical Pathology—2 Volume Set, Elsevier. [11th ed.].

3. Kumar, V., Abbas, A.K., Aster, J.C., Turner, J.R., Perkins, J.A., Robbins, S.L., and Cotran, R.S. (2021). Robbins & Cotran Pathologic Basis of Disease, Elsevier. [10th ed.].

4. Photodynamic Therapy (PDT): PDT Mechanisms;Allison;Clin. Endosc.,2013

5. Lung Cancer Stem Cells—Origin, Characteristics and Therapy;Prabavathy;Stem Cell Investig.,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3